Table 2.

Depletion of S6K1 reduced the tumorigenicity of HCC.

Diseases or Functions Annotation	p-value	Predicted Activation State	Activation z-score
lymphocytic cancer	0.00000862	Decreased	-2.183
breast or colorectal cancer	0.0000549	Decreased	-2.18
endocrine gland tumor	0.000176	Decreased	-2.219
neuroendocrine tumor	0.000196	Decreased	-2.219
lymphoid cancer	0.000291	Decreased	-2.183
breast cancer	0.000916	Decreased	-2.415
breast or ovarian cancer	0.00104	Decreased	-2.415
lymphoproliferative malignancy	0.00126	Decreased	-2.371
liver tumor	0.00264	Decreased	-2.109